11 results
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... Ferritin <100 ng/mL ... diagnosis #management #algorithm ... #cardiology #treatment
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... components of the algorithm ... Procalcitonin <0.5 ng/mL ... Management #Pediatrics #Peds ... Infant #StepByStep #Algorithm
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... functional ID) Treatment ... showed reduced risk ... alissa_shega #iron #deficiency ... diagnosis #management #cardiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Iron Deficiency ... (CHF) Iron deficiency ... TSAT < 20% Risk ... depot iron] Treatment ... pathophysiology #cardiology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... thrombosis; PE = pulmonary ... Anticoagulation #Management #Hematology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... Cataract Plan for Meds ... days before Pulmonary ... one post op Cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... Risk Factors and ... teratogenic GDMT meds ... diagnosis #management #cardiology ... #treatment
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
carries a variable risk ... or folic acid deficiency ... • Copper deficiency ... and reducing the risk ... Syndromes #diagnosis #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
PV, MDS, CML) Treatment ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... Thrombocythemia #ET #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... algorithm 2018. ... influence outcomes and treatment ... cardiovascular or pulmonary ... #algorithm #hematology